Steatohepatitis, Alcoholic

Alexander K. C. Leung; Cham Pion Kao; Andrew L. Wong; Alexander K. C. Leung; Thomas Kolter; Ute Schepers; Konrad Sandhoff; Ute Schepers; Thomas Kolter; Konrad Sandhoff; Ute Schepers; Thomas Kolter; Konrad Sandhoff; Ute Schepers; Thomas Kolter; Konrad Sandhoff; Bennett Myers; David N. Herrmann; Vikram K. Mahajan; Nand Lal Sharma; Surender Kashyap; C. Ronald Scott; Natalie Gall; Katrin Welt; Karin Scharffetter‐­Kochanek; Matthew Harries; Tobias Fischer; Ralf Paus; Cornelius F. Boerkoel; Leah I. Elizondo; Thomas Lücke; Markus M. Nöthen; Marcella Rietschel; Undine E. Lang; Sophie Nicole; Bertrand Fontaine; Alexander K. C. Leung; William Lane M. Robson; Thomas Krieg; Julia Weihrauch; Sergio A. Jiménez; Hugo Ten Cate; Itshak Zusman; Pavel Gurevich; Herzl Ben‐Hur; Jutta Keller; Jiří Litzman; Yaofeng Zhao; Lennart Hammarstöm; Margherita Bergomi; Carlotta Malagoli; Marco Vinceti; Margherita Bergomi; Carlotta Malagoli; Marco Vinceti; Marie-Estelle Dupont; Olivier Guilbaud; Hermann‐Josef Gröne; Zoran V. Popović; Mario Mancini; Batya B. Davidovici; Batsheva Marcos; Edith Orion; Ronni Wolf; Jean Louis Vincent; Giora Feuerstein; James C. Keith; Robert Ruffolo; Cord Sunderkötter; M. Murat Naki; Cevahir Tekcan; M. Murat Naki; Cevahir Tekcan; Amy S. Rawls; Daniel C. Link; Carolina Reitzenstein; Jürgen Kopitz; Michael Cantz; Michael Cantz; Johannes Uhl; Jürgen Kopitz; John‐John B. Schnog; Victor E. A. Gerdes; Bärbel Schütte; Samuel J. Arbes; Darryl C. Zeldin; Alessandra Baumer; Hans‐Peter Zenner; Brandy J. Harvey; Jyh‐Yeuan Lee; Ina L. Urbatsch; Jan Rémi; Soheyl Noachtar; Alexander K. C. Leung; Sarah H. Elsea; Santhosh Girirajan; Chee‐Keong Toh; Cord Sunderkötter; Rebecca Schüle; Lüdger Schöls

doi:10.1007/978-3-540-29676-8_73

Article2021

Fructose and Non-Alcoholic Steatohepatitis

Elke Roeb, Ralf Weiskirchen

Article2021

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention

Frank Tacke, Ralf Weiskirchen

Article2021

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

Roser Pinyol, Sara Torrecilla, Huan Wang, Carla Montironi, Marta Piqué‐Gili, Miguel Torres‐Martín, Wei Qiang Leow, Catherine E. Willoughby, Pierluigi Ramadori, Carmen Andreu-Oller, Patricia Taik, Youngmin A. Lee, Agrin Moeini, Judit Peix, Suzanne Faure‐Dupuy, Tobias Riedl, Svenja Schuehle, Cláudia P. Oliveira, Venâncio Avancini Ferreira Alves, Paolo Boffetta, Anja Lachenmayer, Stephanie Roessler, Beatriz Mínguez, Peter Schirmacher, Jean‐François Dufour, Swan N. Thung, Helen L. Reeves, Flair José Carrilho, Charissa Chang, Andrew Uzilov, Mathias Heikenwälder, Arun J. Sanyal, Scott L. Friedman,

Journal of Hepatology

Article2021

Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?

Masatoshi Kudo

Letter2021

Lack of response to immunotherapy in non-alcoholic steatohepatitis related hepatocellular carcinoma

Masatoshi Kudo

Steatohepatitis, Alcoholic

Discussion(0)

Related publications

Fructose and Non-Alcoholic Steatohepatitis

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?

Lack of response to immunotherapy in non-alcoholic steatohepatitis related hepatocellular carcinoma